101 USD
-7.98 (-7.32%)
101.42 USD
+0.42 (+0.42%)
Taking everything into account, GRAL scores 4 out of 10 in our fundamental rating. GRAL was compared to 525 industry peers in the Biotechnology industry. While GRAL has a great health rating, there are worries on its profitability. GRAL is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
- In the past year GRAL has reported negative net income.
- GRAL had a negative operating cash flow in the past year.
- GRAL had negative earnings in each of the past 5 years.
- GRAL had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
- GRAL has a better Return On Assets (-15.62%) than 79.43% of its industry peers.
- With an excellent Return On Equity value of -18.14%, GRAL belongs to the best of the industry, outperforming 84.19% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -15.62% | ||
| ROE | -18.14% | ||
| ROIC | N/A |
ROA(3y)-71.58%
ROA(5y)N/A
ROE(3y)-79.12%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- With a decent Gross Margin value of 46.88%, GRAL is doing good in the industry, outperforming 75.05% of the companies in the same industry.
- GRAL's Gross Margin has improved in the last couple of years.
- The Profit Margin and Operating Margin are not available for GRAL so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 46.88% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y28.32%
GM growth 5YN/A
2. Health
2.1 Basic Checks
- GRAL does not have a ROIC to compare to the WACC, probably because it is not profitable.
- The number of shares outstanding for GRAL has been increased compared to 1 year ago.
- Compared to 5 years ago, GRAL has less shares outstanding
- GRAL has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- Based on the Altman-Z score of 0.70, we must say that GRAL is in the distress zone and has some risk of bankruptcy.
- Looking at the Altman-Z score, with a value of 0.70, GRAL is in the better half of the industry, outperforming 62.86% of the companies in the same industry.
- There is no outstanding debt for GRAL. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.7 |
ROIC/WACCN/A
WACC8.88%
2.3 Liquidity
- GRAL has a Current Ratio of 7.61. This indicates that GRAL is financially healthy and has no problem in meeting its short term obligations.
- With a decent Current ratio value of 7.61, GRAL is doing good in the industry, outperforming 72.95% of the companies in the same industry.
- A Quick Ratio of 7.61 indicates that GRAL has no problem at all paying its short term obligations.
- Looking at the Quick ratio, with a value of 7.61, GRAL is in the better half of the industry, outperforming 73.14% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 7.61 | ||
| Quick Ratio | 7.61 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 90.18% over the past year.
- Looking at the last year, GRAL shows a very negative growth in Revenue. The Revenue has decreased by -21.40% in the last year.
- Measured over the past years, GRAL shows a very strong growth in Revenue. The Revenue has been growing by 104.84% on average per year.
EPS 1Y (TTM)90.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%37.56%
Revenue 1Y (TTM)-21.4%
Revenue growth 3Y104.84%
Revenue growth 5YN/A
Sales Q2Q%26.33%
3.2 Future
- The Earnings Per Share is expected to grow by 12.99% on average over the next years. This is quite good.
- GRAL is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 23.95% yearly.
EPS Next Y82.14%
EPS Next 2Y35.16%
EPS Next 3Y22.46%
EPS Next 5Y12.99%
Revenue Next Year18.12%
Revenue Next 2Y18.75%
Revenue Next 3Y19.11%
Revenue Next 5Y23.95%
3.3 Evolution
- The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for GRAL. In the last year negative earnings were reported.
- Also next year GRAL is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- A more expensive valuation may be justified as GRAL's earnings are expected to grow with 22.46% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y35.16%
EPS Next 3Y22.46%
5. Dividend
5.1 Amount
- No dividends for GRAL!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
GRAIL INC / GRAL FAQ
Can you provide the ChartMill fundamental rating for GRAIL INC?
ChartMill assigns a fundamental rating of 4 / 10 to GRAL.
Can you provide the valuation status for GRAIL INC?
ChartMill assigns a valuation rating of 1 / 10 to GRAIL INC (GRAL). This can be considered as Overvalued.
How profitable is GRAIL INC (GRAL) stock?
GRAIL INC (GRAL) has a profitability rating of 2 / 10.
What is the earnings growth outlook for GRAIL INC?
The Earnings per Share (EPS) of GRAIL INC (GRAL) is expected to grow by 82.14% in the next year.